Health ❯ Healthcare

Cancer Statistics

Incidence Rates Survival Rates Mortality Rates Breast Cancer Statistics Global Health Colorectal Cancer Bowel Cancer Prostate Cancer Incidence Bowel Cancer Statistics Prostate Cancer Statistics

3 ARTICLES

3w ago

Trodelvy Approved in U.S. and EU as First‑Line Option for Metastatic Triple‑Negative Breast Cancer

This shift toward antibody‑drug conjugates could change frontline care by giving patients longer tumor control as survival benefits and access questions remain

4 ARTICLES

4w ago

California Study Links Birth and Parental Factors to Early‑Onset Colorectal Cancer Risk

7 ARTICLES

4w ago

Kidney Cancer Often Missed Until Late, Experts Warn

5 ARTICLES

last mo.

Erleada Plus Hormone Therapy Cuts Recurrence and Death in High‑Risk Localized Prostate Cancer

3 ARTICLES

last mo.

FDA Opens Early Access to KRAS-Targeting Pancreatic Cancer Pill After Strong Survival Data

10 ARTICLES

2mo ago

Roche Launches 7-Minute Under-the-Skin Lung Cancer Shot in India

7 ARTICLES

2mo ago

FDA Authorizes Early Access to Daraxonrasib for Pancreatic Cancer Patients

5 ARTICLES

3mo ago

Revolution Medicines’ Pancreatic Cancer Drug Lands ASCO Plenary After Phase 3 Survival Gain

6 ARTICLES

3mo ago

Pre-Surgery Pembrolizumab Shows Zero Relapses in MSI-High Bowel Cancer Trial

3 ARTICLES

3mo ago

Experimental Pill Doubles Survival in Advanced Pancreatic Cancer Trial

6 ARTICLES

5mo ago

World Cancer Day Spurs Screening Push as Study Finds 38% of Cancers Preventable

9 ARTICLES

5mo ago

NHS England Lowers Bowel Screening FIT Trigger to 80µg Hb/g Next Month

5 ARTICLES

5mo ago

NICE Backs Talazoparib–Enzalutamide for NHS Use in England

3 ARTICLES

6mo ago

Hospital Admits Misreported Smear Cost Curative Window in Shrewsbury Mother’s Cervical Cancer

5 ARTICLES

6mo ago

Watchdog Orders Apology and Overhaul After Essex Cancer Treatment Delays

4 ARTICLES

6mo ago

U.S. Updates Cervical Screening: Self-Collected HPV Tests Endorsed, Insurer Coverage Set for 2027

4 ARTICLES

6mo ago

IAEA Hails Pakistan’s PAEC-Led Expansion of Cancer Care

Cancer Statistics

Trodelvy Approved in U.S. and EU as First‑Line Option for Metastatic Triple‑Negative Breast Cancer

California Study Links Birth and Parental Factors to Early‑Onset Colorectal Cancer Risk

Kidney Cancer Often Missed Until Late, Experts Warn

Erleada Plus Hormone Therapy Cuts Recurrence and Death in High‑Risk Localized Prostate Cancer

Drug Combination Cuts Progression in Aggressive Metastatic Prostate Cancer

NHS Mobile Units Detect More Than 10,600 Lung Cancers

Cochrane Review Finds PSA Screening Modestly Cuts Prostate Cancer Deaths

FDA Opens Early Access to KRAS-Targeting Pancreatic Cancer Pill After Strong Survival Data

Roche Launches 7-Minute Under-the-Skin Lung Cancer Shot in India

FDA Authorizes Early Access to Daraxonrasib for Pancreatic Cancer Patients

Never miss stories about

Cancer Statistics

Revolution Medicines’ Pancreatic Cancer Drug Lands ASCO Plenary After Phase 3 Survival Gain

Pre-Surgery Pembrolizumab Shows Zero Relapses in MSI-High Bowel Cancer Trial

Experimental Pill Doubles Survival in Advanced Pancreatic Cancer Trial

World Cancer Day Spurs Screening Push as Study Finds 38% of Cancers Preventable

NHS England Lowers Bowel Screening FIT Trigger to 80µg Hb/g Next Month

NICE Backs Talazoparib–Enzalutamide for NHS Use in England

Hospital Admits Misreported Smear Cost Curative Window in Shrewsbury Mother’s Cervical Cancer

Watchdog Orders Apology and Overhaul After Essex Cancer Treatment Delays

U.S. Updates Cervical Screening: Self-Collected HPV Tests Endorsed, Insurer Coverage Set for 2027

IAEA Hails Pakistan’s PAEC-Led Expansion of Cancer Care

Never miss stories about

Cancer Statistics